Windtree Therapeutics Stock Fundamentals
| WINTW Stock | USD 0.0009 0.0001 12.50% |
Windtree Therapeutics fundamentals help investors to digest information that contributes to Windtree Therapeutics' financial success or failures. It also enables traders to predict the movement of Windtree Pink Sheet. The fundamental analysis module provides a way to measure Windtree Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Windtree Therapeutics pink sheet.
Windtree |
Windtree Therapeutics Company Cash Per Share Analysis
Windtree Therapeutics' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Windtree Therapeutics Cash Per Share | 0.64 X |
Most of Windtree Therapeutics' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Windtree Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Windtree Therapeutics has a Cash Per Share of 0.64 times. This is much higher than that of the sector and significantly higher than that of the Cash Per Share industry. The cash per share for all United States stocks is notably lower than that of the firm.
Windtree Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Windtree Therapeutics's current stock value. Our valuation model uses many indicators to compare Windtree Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Windtree Therapeutics competition to find correlations between indicators driving Windtree Therapeutics's intrinsic value. More Info.Windtree Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Windtree Therapeutics' earnings, one of the primary drivers of an investment's value.Windtree Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Windtree Therapeutics' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Windtree Therapeutics could also be used in its relative valuation, which is a method of valuing Windtree Therapeutics by comparing valuation metrics of similar companies.Windtree Therapeutics is currently under evaluation in cash per share category among its peers.
Windtree Fundamentals
| Return On Equity | -0.45 | |||
| Return On Asset | -0.16 | |||
| EBITDA | (77.32 M) | |||
| Net Income | (67.64 M) | |||
| Cash And Equivalents | 16.93 M | |||
| Cash Per Share | 0.64 X | |||
| Total Debt | 18.78 M | |||
| Debt To Equity | 0.27 % | |||
| Current Ratio | 2.95 X | |||
| Cash Flow From Operations | (23.66 M) | |||
| Number Of Employees | 31 | |||
| Beta | -0.15 | |||
| Total Asset | 74.79 M | |||
| Z Score | -3.3 | |||
| Net Asset | 74.79 M |
About Windtree Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Windtree Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Windtree Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Windtree Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Windtree Therapeutics, Inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Windtree Pink Sheet Analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.